COVID-19 Policies and Sexually Transmitted Infections in 22 US States, January 2020-December 2021.

Am J Public Health

Catherine C. Pollack is with the Decision Systems Group, Johns Hopkins University Applied Physics Laboratory, Laurel, MD. Georgia H. Redd and Collin M. Timm are with the Applied Biological Sciences Group, Johns Hopkins University Applied Physics Laboratory. Yukari C. Manabe is with the Division of Infectious Diseases, Johns Hopkins University School of Medicine, Baltimore, MD.

Published: February 2025

To quantify the effects of 5 jurisdiction-level COVID-19 policies on chlamydia, gonorrhea, and syphilis rates in 22 US jurisdictions between January 2020 and December 2021. We applied a mixed-effects, negative binomial, interrupted time series model to estimate the impact that each policy of interest had on reported cases. Mandatory stay-at-home periods were associated with a decrease in reported chlamydia (incident rate ratio [IRR] = 0.75; 95% confidence interval [CI] = 0.71, 0.80) and gonorrhea (IRR = 0.85; 95% CI = 0.78, 0.94) cases. We also observed decreased chlamydia case reporting when gatherings were restricted to 10 people (IRR = 0.88; 95% CI = 0.85, 0.92), masking was recommended (IRR = 0.90; 95% CI = 0.85, 0.97), or polymerase chain reaction testing was limited to symptomatic individuals (IRR = 0.72; 95% CI = 0.67, 0.77). Universal vaccine access corresponded to decreases in reported gonorrhea (IRR = 0.83; 95% CI = 0.75, 0.92) but increases in syphilis (IRR = 1.33; 95% CI = 1.04, 1.70) cases. We also observed effects by sex, race, and ethnicity. COVID-19 policies had disparate effects on sexually transmitted infection rates that varied across demographic groups. Overall results were attenuated after the first lockdown period (March-May 2020), but demographic variations persisted. (. Published online ahead of print February 21, 2025:e1-e10. https://doi.org/10.2105/AJPH.2024.307957).

Download full-text PDF

Source
http://dx.doi.org/10.2105/AJPH.2024.307957DOI Listing

Publication Analysis

Top Keywords

covid-19 policies
12
sexually transmitted
8
cases observed
8
95% ci = 085
8
95%
7
policies sexually
4
transmitted infections
4
infections states
4
states january
4
january 2020-december
4

Similar Publications

Community pharmacy services in the late COVID-19 period: What has driven change?

Res Social Adm Pharm

March 2025

WHO Collaborating Centre for Pharmaceutical Pricing and Reimbursement Policies, Pharmacoeconomics Department, Gesundheit Österreich GmbH (GÖG / Austrian National Public Health Institute), Stubenring 6, 1010, Vienna, Austria; Department of Health Policy, London School of Economics and Political Science, Houghton Street, London, WC2A 2AE, UK. Electronic address:

Background: Community pharmacy appears to have undergone considerable change over the years.

Objectives: The objective of this research is to study the range of community pharmacy services provided in late stages of the COVID-19 pandemic and during the last decades and to identify potential drivers for change.

Methods: Four European countries (Austria, England, Estonia, and Portugal), which represent a balance in terms of income, organization of the health system and pharmacy services, were selected as case studies.

View Article and Find Full Text PDF

Objectives: This study aims to explore the perceptions of patients affected by COVID-19 and their families regarding the challenges faced, coping strategies used and lessons learnt in Pakistan.

Design: A qualitative exploratory descriptive approach was used to explore the real-time experiences of the participants.

Setting: The study was carried out in a tertiary care hospital in Karachi, Pakistan.

View Article and Find Full Text PDF

Objectives: ;Antimicrobial stewardship programs (ASP) aim to improve the quality of medical prescribing and contain antimicrobial resistance (AMR). There is little information on the implementation of ASP in hospitals in Mexico. This study aimed to characterize ASP in a sample of hospitals in Mexico and to identify the facilitators and barriers perceived in their implementation, including the COVID-19 pandemic.

View Article and Find Full Text PDF

Better Together: Implementation of a Public Health Learning Community During the COVID-19 Pandemic.

Am J Public Health

April 2025

Kristen M. Brown, Brigette Courtot, Zara Porter, and Sofia Hinojosa are with the Health Policy Center, Urban Institute, Washington, DC.

The Centers for Disease Control and Prevention's Partnering for Vaccine Equity program was developed during the COVID-19 public health emergency to fund more than 500 community-based organizations working to improve vaccine equity. Organizations were supported by a virtual learning community where members received tailored learning content, peer-to-peer learning opportunities, and resources that facilitated deployment of vaccine-related programming during a dynamic pandemic. Process evaluation metrics indicate successful implementation of the learning community.

View Article and Find Full Text PDF

Population-Level Risks for HIV Mortality During the COVID-19 Pandemic in the United States by Demographic Characteristics and Medicaid Access, 2020‒2021.

Am J Public Health

April 2025

Donrie Purcell is with the Satcher Health Leadership Institute, Morehouse School of Medicine (MSM), Atlanta, GA. Wayne A. Duffus is with the Department of Medicine, Division of Infectious Diseases, University of South Carolina School of Medicine, Columbia. Maisha Standifer is with the Satcher Health Leadership Institute and Department of Community Health and Preventive Medicine, MSM. Robert Mayberry is with the Department of Community Health and Preventive Medicine and the MSM Research Design and Biostatistics Core, MSM. Sonja S. Hutchins is with the Department of Community Health and Preventive Medicine, MSM.

To evaluate the impact of the COVID-19 pandemic on HIV mortality rates with a focus on demographic predictors and Medicaid access. Using Wide-Ranging Online Data for Epidemiologic Research, we conducted a descriptive study comparing HIV mortality in the United States 2 years before the COVID-19 pandemic (2018-2019) and the initial 2 years of the pandemic (2020-2021), and identifying HIV mortality factors during the pandemic. During the first 2 years of the pandemic, crude HIV death rates increased and then decreased marginally.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!